Home > Share Market > Stocks > Glenmark pharmaceuticals > Financial Statements > GLENMARK Balance Sheet

Glenmark Pharmaceuticals Ltd Financial Statements

Glenmark Pharmaceuticals Ltd Balance Sheet

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 28.20 28.20 28.20 28.20
Preference capital -- -- -- --
Reserves 7,036 6,042 5,577 5,135
Net worth 7,065 6,071 5,605 5,163
Minority interest
Debt 4,687 4,869 4,449 4,639
Deferred tax liabilities (net) 346 332 379 408
Total liabilities 12,098 11,270 10,432 10,211
Fixed assets 6,511 6,250 5,069 4,151
Intangible assets
Investments 24.60 24.60 29.70 14.70
Deferred tax asset (net) 1,852 1,771 1,762 1,729
Net working capital 2,571 2,113 2,634 3,081
Inventories 2,277 2,136 2,252 2,031
Inventory Days 75.90 73.30 -- 81.70
Sundry debtors 2,572 2,409 2,195 2,332
Debtor days 85.80 82.60 -- 93.80
Other current assets 1,546 1,298 1,423 1,512
Sundry creditors (2,248) (2,149) (2,240) (1,910)
Creditor days 75 73.70 -- 76.80
Other current liabilities (1,575) (1,581) (995) (883)
Cash 1,139 1,111 938 1,235
Total assets 12,098 11,270 10,432 10,211

Invest in at ZERO Delivery Brokerage. Join 22 Lac+ Happy Clients